Atopic dermatitis (AD) is a complex skin disease frequently associated with other diseases of
the atopic diathesis. Recent evidence supports the concept that AD can also recognize other …

Atopic eczema (AE) is a challenge for modern medicine, because it is prevalent, severely
affects quality of life of patients and their families, and causes high socioeconomic costs. The …

Background Atopic dermatitis (AD) shows very high prevalence in Asia, with a large unmet
need for effective therapeutics. Direct comparisons between European American (EA) and …

В издании обобщены исследования авторов и литературные данные по проблеме
атопического дерматита у детей. Представлены эпидемиология, этиология, патогенез …

Atopic dermatitis (AD) is the most common inflammatory skin disease, but treatment options
for moderate‐to‐severe disease are limited. Ustekinumab is an IL‐12/IL‐23p40 antagonist …

Atopic dermatitis (AD) is a common chronic inflammatory skin disease that predominantly
affects children. However, it can persist in adulthood and/or start at older ages. Due to its …

Atopic dermatitis (AD) is one of the most common, chronic inflammatory skin diseases with a
significant physical, emotional and socioeconomic burden. In recent years the …

Biologic agents (also termed biologicals or biologics) are therapeutics that are synthesized
by living organisms and directed against a specific determinant, for example, a cytokine or …

Severe atopic dermatitis, which affects both adults and children, is a debilitating disorder
with a significant decline of patients' quality of life. Although aetiopathogenic factors are …

Atopic dermatitis (AD) is a common allergic inflammatory skin condition mainly caused by
gene variants, immune disorders, and environmental risk factors. The T helper (Th) 2 …